Denali Therapeutics, Inc. (DNLI)
22.55
-0.30
(-1.31%)
USD |
NASDAQ |
Sep 03, 12:16
Denali Therapeutics Net Income (Annual) : -512.54M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -512.54M |
| December 31, 2024 | -422.77M |
| December 31, 2023 | -145.22M |
| December 31, 2022 | -325.99M |
| December 31, 2021 | -290.58M |
| December 31, 2020 | 71.14M |
| Date | Value |
|---|---|
| December 31, 2019 | -197.61M |
| December 31, 2018 | -36.24M |
| December 31, 2017 | -88.18M |
| December 31, 2016 | -86.65M |
| December 31, 2015 | -16.79M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 30.11M |
| Oncolytics Biotech, Inc. | -28.76M |
| Sangamo Therapeutics, Inc. | -122.93M |
| Sarepta Therapeutics, Inc. | -713.41M |
| Anixa Biosciences, Inc. | -11.03M |